Upvote
Downvote
ViiV (GSK) Director, Epidemiology & Real World Evidence
Share Job
- Suggest Revision
Full-time
- ViiV Healthcare has established presence in 16 countries and we are uniquely positioned to be at the forefront of advancing HIV treatment, care, prevention and cure because we are the only pharmaceutical company 100% focused on HIV.Through our focus on patient-centered innovation we have developed a strong portfolio of medicines that are advancing treatment and care for people living with HIV around the world.
- The primary focus is on the growth portfolio namely dolutegravir and cabotegravir based regimens as well as other assets and asset combinations from phase IIb through to in-market such as Tivicay, Triumeq as well as Juluca, Dovato, CAB/RPV, CAB prevention, fostemsavir, Maturation Inhibitors and other novel agents early in development pipeline.
- The Director, Epidemiology & Real-World Evidence reports to VP, Global Head of Epidemiology & Real World Evidence.
- The Director will be based out of ViiV's US Headquarters in Durham, NC (Cary/Wake Forest/Chapel Hill/Raleigh area) OR our International Headquarters in London, UK & is eligible for a relocation package within the US &/or UK.This role will provide YOU the opportunity to lead key activities to progress YOUR career.
- These responsibilities include some of the following:Work with Head of Epidemiology & Real World Evidence to develop product specific epidemiology strategy and conduct research studies to accomplish that strategy for ViiV Healthcare portfolio.
Active Job
Updated TodaySimilar Job
Relevance
Active